Alta Sciences

MARCH 8, 2024

Inside the Altascientist: Considerations for Safe and Compliant HPAPI Manufacturing pmjackson Fri, 03/08/2024 - 19:35 In recent years, advancements in oncological research have fueled a surge in demand for highly potent active pharmaceutical ingredients ( HPAPIs ). billion by 2029. WHAT IS THE ALTASCIENTIST ?

Compliance 52

Compliance Engineering Regulations Drug Development 52

Policy Prescription

MARCH 26, 2021

Would you vote for legislation to lower drug prices that would lead to a five percent reduction in pharmaceutical innovation — yet simultaneously create a health system in which all Americans could afford the prescription drugs they need? The savings to the government would be about $345 billion between 2023-2029 because of lower prices.

Drugs 52

Drugs Government Vaccine Pharmaceuticals 52

Vial

MARCH 1, 2024

Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). billion by 2029. ’s services include supporting life sciences research, analytical solutions, and diagnostics or developing and manufacturing therapeutic interventions.

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

Agency IQ

MAY 28, 2024

DWD establishes “watch list” to monitor substances of concern The 2020 DWD mandated that he Commission set up a watch list “addressing substances or compounds of concern to the public or the scientific community on health grounds […] such as pharmaceuticals, endocrine-disrupting compounds and microplastics.”

Compliance 40

Compliance Production Pharmaceuticals Treatment 40

Agency IQ

FEBRUARY 2, 2024

In some less common cases, a test or diagnostic may be technically classified as a biological product and regulated under the Center for Biologics Evaluation and Research (CBER) (e.g., The proposal will be discussed at the Council of the EU Working Party on Pharmaceuticals and Medical Devices, taking place January 30. In the U.S.,

FDA 40

FDA Laboratories Regulations Production 40